Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alkem Laboratories Ltd. ( (IN:ALKEM) ) has issued an announcement.
Alkem Laboratories has notified the stock exchanges that it will hold a virtual meeting with Millennium Capital Management on March 26, 2026, as part of its regular engagement with analysts and institutional investors. The planned interaction underscores the company’s ongoing efforts to maintain transparent communication with the investment community, though the schedule remains subject to change based on exigencies from either party.
More about Alkem Laboratories Ltd.
Alkem Laboratories Ltd. is an Indian pharmaceutical company engaged in the development, manufacture, and marketing of generic formulations and active pharmaceutical ingredients. It has a significant presence in domestic and international markets, focusing on therapeutic areas such as anti-infectives, gastro-intestinal, pain management, and chronic therapies.
Average Trading Volume: 21,667
Technical Sentiment Signal: Hold
Current Market Cap: 626.6B INR
See more insights into ALKEM stock on TipRanks’ Stock Analysis page.